Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Affiliate content. See how LeanBliss and SuperThin stack up against each other when it comes to weight loss support.

26 (UPI) --The U.S. Food and Drug Administration has approved a new ... Health News // 19 hours ago Health plans at 1 in 5 large companies cover weight-loss drugs for employees Only a fifth ...

The first new ... FDA's Center for Drug Evaluation and Research. "This drug takes the first new approach to schizophrenia treatment in decades," she said in an agency news release. "This approval ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...

The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...

Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., ...

The FDA has approved a new injectable form of the multiple sclerosis drug ocrelizumab for use in adults with relapsing and progressive forms of the disease. Multiple sclerosis occurs when the body ...

A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...

The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on Thursday approved ... drugs used for weight loss work?

Sept. 26 (UPI) --The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday. The drug, generically called Cobenfy, is the first oral ...